
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Adrenocortical carcinoma MRI
Introduction
Overview
Overview
MRI scans are helpful in differentiating between adrenal adenoma, carcinoma, and metastatic lesions. Due to the multi-planar capability of MRI, direct invasion of adjacent organs may be better shown. Inferior vena cava invasion has been reported in 9% to 19% of cases at presentation.
MRI Findings in adrenocortical carcinoma
MRI Findings in adrenocortical carcinoma
- Adrenocortical carcinomas are usually large and appear as heterogeneous masses on both T1- and T2-weighted images owing to the presence of internal hemorrhage and necrosis.[1]
- Adrenocortical carcinoma may contain foci of intra-cytoplasmic lipid, which results in a loss of signal intensity on out-of-phase images.[2]
- Large adrenal carcinomas tend to invade the adrenal vein and inferior vena cava.[1]
- On MRI, ACCs appear iso-intense to hypo-intense relative to liver parenchyma on T1-weighted images and hyper-intense relative to liver parenchyma on T2-weighted images.[3]
- On chemical-shift MRI, the presence of intracellular lipid can cause regions of signal loss on out-of-phase images relative to in-phase images.[4]
- Inferior vena cava invasion has been reported in 9% to 19% of cases at presentation.
- Due to the multi-planar capability of MRI, direct invasion of adjacent organs may be better shown.
MRI Examples of adrenocortical carcinoma
MRI Examples of adrenocortical carcinoma

Source: Case courtesy of Radswiki, Radiopaedia.org, rID: 11176
References
References
- ↑ 1.0 1.1 Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB; et al. (2011). “Adrenocortical carcinoma: the range of appearances on CT and MRI”. AJR Am J Roentgenol. 196 (6): W706–14. doi:10.2214/AJR.10.5540. PMID 21606258.
- ↑ Ng L, Libertino JM (2003). “Adrenocortical carcinoma: diagnosis, evaluation and treatment”. J Urol. 169 (1): 5–11. doi:10.1097/01.ju.0000030148.59051.35. PMID 12478091.
- ↑ Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB; et al. (2011). “Adrenocortical carcinoma: the range of appearances on CT and MRI”. AJR Am J Roentgenol. 196 (6): W706–14. doi:10.2214/AJR.10.5540. PMID 21606258.
- ↑ Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB; et al. (2011). “Adrenocortical carcinoma: the range of appearances on CT and MRI”. AJR Am J Roentgenol. 196 (6): W706–14. doi:10.2214/AJR.10.5540. PMID 21606258.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]







